FI955311A0 - Farmaseuttinen koostumuspohja - Google Patents
Farmaseuttinen koostumuspohjaInfo
- Publication number
- FI955311A0 FI955311A0 FI955311A FI955311A FI955311A0 FI 955311 A0 FI955311 A0 FI 955311A0 FI 955311 A FI955311 A FI 955311A FI 955311 A FI955311 A FI 955311A FI 955311 A0 FI955311 A0 FI 955311A0
- Authority
- FI
- Finland
- Prior art keywords
- pharmaceutical composition
- composition base
- base
- pharmaceutical
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dispersion Chemistry (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH337594 | 1994-11-09 | ||
CH59595 | 1995-03-02 |
Publications (2)
Publication Number | Publication Date |
---|---|
FI955311A0 true FI955311A0 (fi) | 1995-11-06 |
FI955311A FI955311A (fi) | 1996-05-10 |
Family
ID=25685065
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI955311A FI955311A (fi) | 1994-11-09 | 1995-11-06 | Farmaseuttinen koostumuspohja |
FI955312A FI955312A (fi) | 1994-11-09 | 1995-11-06 | Staurosporiinijohdannaisen intravenoosit liuokset |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI955312A FI955312A (fi) | 1994-11-09 | 1995-11-06 | Staurosporiinijohdannaisen intravenoosit liuokset |
Country Status (11)
Country | Link |
---|---|
US (1) | US5658898A (fi) |
EP (2) | EP0711557A1 (fi) |
JP (2) | JPH08208522A (fi) |
KR (2) | KR960016908A (fi) |
AU (2) | AU3661795A (fi) |
CA (2) | CA2162341A1 (fi) |
FI (2) | FI955311A (fi) |
HU (2) | HUT74423A (fi) |
IL (2) | IL115912A0 (fi) |
NO (2) | NO954486L (fi) |
NZ (2) | NZ280420A (fi) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996037192A1 (en) * | 1995-05-26 | 1996-11-28 | Vesifact Ag | Pharmaceutical and cosmetic compositions containing sphingo- and glycolipids |
EP0866689A1 (de) * | 1995-12-12 | 1998-09-30 | Vesifact Ag | Cortisolspray zur topischen verabreichung |
DE19622224A1 (de) | 1996-02-16 | 1997-08-21 | Max Planck Gesellschaft | Phosphatidyloligoglycerine |
DK0850646T3 (da) * | 1996-06-18 | 2008-05-13 | Kyowa Hakko Kogyo Kk | Liposompræparater af indolocarbazol-derivater |
US6537561B1 (en) * | 1997-02-27 | 2003-03-25 | Nippon Shinyaku Co., Ltd. | Fat emulsion for oral administration |
IL135989A0 (en) * | 1997-11-14 | 2001-05-20 | Skyepharma Inc | Processes for the production of multivesicular liposomes |
TW592713B (en) * | 1998-05-11 | 2004-06-21 | Ciba Sc Holding Ag | Use of nanodispersions in cosmetic end formulations |
US7381423B2 (en) | 1998-05-11 | 2008-06-03 | Ciba Specialty Chemicals Corp. | Use of nanodispersions in cosmetic end formulations |
TWI241915B (en) * | 1998-05-11 | 2005-10-21 | Ciba Sc Holding Ag | A method of preparing a pharmaceutical end formulation using a nanodispersion |
US6200968B1 (en) * | 1998-08-06 | 2001-03-13 | Cephalon, Inc. | Particle-forming compositions containing fused pyrrolocarbazoles |
US7795246B2 (en) * | 1998-08-06 | 2010-09-14 | Cephalon, Inc. | Particle-forming compositions containing fused pyrrolocarbazoles |
DE69929128T2 (de) * | 1998-08-31 | 2006-06-29 | Nipro Corp. | Nährstoffinfusionspräparat |
GB9903547D0 (en) * | 1999-02-16 | 1999-04-07 | Novartis Ag | Organic compounds |
GB9924962D0 (en) * | 1999-10-21 | 1999-12-22 | Mrc Collaborative Centre | Allosteric sites on muscarinic receptors |
CN1582150B (zh) * | 2001-10-30 | 2011-09-07 | 诺瓦提斯公司 | 作为flt3受体酪氨酸激酶活性抑制剂的星形孢菌素衍生物 |
KR100422763B1 (ko) * | 2002-01-17 | 2004-03-12 | 주식회사 태평양 | 경피흡수 촉진 능력이 우수한 식물성 나노입자의 제조 및이를 함유하는 화장료 및 의약용 외용제 조성물 |
KR100490365B1 (ko) * | 2002-04-25 | 2005-05-17 | 한불화장품주식회사 | 화장료용 나노 베지클을 함유하는 화장료 조성물 |
CA2492989C (en) * | 2002-07-23 | 2012-11-20 | Novartis Ag | Ophthalmic ointment composition comprising a drug, an ointment base and a solubilizing/dispersing agent |
KR20110005747A (ko) * | 2003-03-03 | 2011-01-18 | 플로리안 랑 | 진단 및 치료 표적으로서의 sgk1 |
GB0305941D0 (en) * | 2003-03-14 | 2003-04-23 | Camurus Ab | Composition |
CN100536850C (zh) | 2003-08-08 | 2009-09-09 | 诺瓦提斯公司 | 包含星孢素的组合 |
MX2007001155A (es) * | 2004-07-29 | 2007-08-14 | Creabilis Therapeutics Spa | Uso de inhibidores de k-252a y de quinasa para la prevencion o el tratamiento de patologias asociadas con hmgb1. |
JP5135852B2 (ja) * | 2007-03-30 | 2013-02-06 | 日油株式会社 | 可溶化用組成物 |
KR100849537B1 (ko) * | 2007-07-04 | 2008-07-31 | 유효경 | 코엔자임 큐텐의 나노에멀젼 조성물 |
US20090155352A1 (en) * | 2007-11-20 | 2009-06-18 | Cephalon, Inc. | Microemulsion containing indolocarbazole compound and dosage forms containing the same |
JP2012051823A (ja) * | 2010-08-31 | 2012-03-15 | Fujifilm Corp | 難容性薬物含有水中油型乳化組成物及びその製造方法 |
KR101494594B1 (ko) | 2011-08-30 | 2015-02-23 | 주식회사 종근당 | 약리학적 활성물질의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물 |
EP2787977A4 (en) * | 2011-12-09 | 2015-05-06 | Univ California | LIPOSOMAL ACTIVE INVERTING |
KR101586791B1 (ko) | 2012-12-28 | 2016-01-19 | 주식회사 종근당 | GnRH 유도체의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물 |
US11278494B1 (en) | 2021-01-22 | 2022-03-22 | Pacira Pharmaceuticals, Inc. | Manufacturing of bupivacaine multivesicular liposomes |
US11357727B1 (en) | 2021-01-22 | 2022-06-14 | Pacira Pharmaceuticals, Inc. | Manufacturing of bupivacaine multivesicular liposomes |
US11033495B1 (en) | 2021-01-22 | 2021-06-15 | Pacira Pharmaceuticals, Inc. | Manufacturing of bupivacaine multivesicular liposomes |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6348214A (ja) * | 1986-08-18 | 1988-02-29 | Morishita Seiyaku Kk | 1−〔2−(2,4−ジクロロフエニル)−3−メチル−1−ペンテニル〕−1h−イミダゾ−ルを含有する水中油型脂肪乳剤 |
US5093330A (en) * | 1987-06-15 | 1992-03-03 | Ciba-Geigy Corporation | Staurosporine derivatives substituted at methylamino nitrogen |
IL86632A0 (en) * | 1987-06-15 | 1988-11-30 | Ciba Geigy Ag | Derivatives substituted at methyl-amino nitrogen |
CH677886A5 (fi) * | 1989-06-26 | 1991-07-15 | Hans Georg Prof Dr Weder | |
AU675930B2 (en) * | 1992-02-18 | 1997-02-27 | Pharmos Corp. | Dry compositions for preparing submicron emulsions |
AU1911095A (en) * | 1994-02-18 | 1995-09-04 | Cephalon, Inc. | Aqueous indolocarbazole solutions |
-
1995
- 1995-11-01 EP EP95810687A patent/EP0711557A1/de not_active Withdrawn
- 1995-11-01 EP EP95810686A patent/EP0711556A1/de not_active Withdrawn
- 1995-11-02 AU AU36617/95A patent/AU3661795A/en not_active Abandoned
- 1995-11-02 AU AU36616/95A patent/AU3661695A/en not_active Abandoned
- 1995-11-06 FI FI955311A patent/FI955311A/fi unknown
- 1995-11-06 FI FI955312A patent/FI955312A/fi unknown
- 1995-11-07 HU HU9503199A patent/HUT74423A/hu unknown
- 1995-11-07 HU HU9503198A patent/HUT78026A/hu unknown
- 1995-11-07 US US08/553,126 patent/US5658898A/en not_active Expired - Fee Related
- 1995-11-07 NZ NZ280420A patent/NZ280420A/en unknown
- 1995-11-07 CA CA002162341A patent/CA2162341A1/en not_active Abandoned
- 1995-11-07 NZ NZ280419A patent/NZ280419A/en unknown
- 1995-11-07 CA CA002162342A patent/CA2162342A1/en not_active Abandoned
- 1995-11-08 IL IL11591295A patent/IL115912A0/xx unknown
- 1995-11-08 IL IL11591395A patent/IL115913A0/xx unknown
- 1995-11-08 NO NO954486A patent/NO954486L/no unknown
- 1995-11-08 KR KR1019950040197A patent/KR960016908A/ko not_active Application Discontinuation
- 1995-11-08 NO NO954485A patent/NO954485L/no unknown
- 1995-11-08 JP JP7289511A patent/JPH08208522A/ja active Pending
- 1995-11-08 JP JP7289508A patent/JPH08208486A/ja active Pending
- 1995-11-08 KR KR1019950040196A patent/KR960016890A/ko not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
HUT74423A (en) | 1996-12-30 |
JPH08208486A (ja) | 1996-08-13 |
NO954485D0 (no) | 1995-11-08 |
AU3661695A (en) | 1996-05-23 |
HU9503198D0 (en) | 1996-01-29 |
FI955312A (fi) | 1996-05-10 |
NO954486D0 (no) | 1995-11-08 |
FI955312A0 (fi) | 1995-11-06 |
US5658898A (en) | 1997-08-19 |
NO954486L (no) | 1996-05-10 |
EP0711557A1 (de) | 1996-05-15 |
HU9503199D0 (en) | 1996-01-29 |
EP0711556A1 (de) | 1996-05-15 |
FI955311A (fi) | 1996-05-10 |
IL115913A0 (en) | 1996-01-31 |
HUT78026A (hu) | 1999-05-28 |
CA2162341A1 (en) | 1996-05-10 |
KR960016890A (ko) | 1996-06-17 |
KR960016908A (ko) | 1996-06-17 |
AU3661795A (en) | 1996-05-23 |
NZ280419A (en) | 1997-04-24 |
CA2162342A1 (en) | 1996-05-10 |
IL115912A0 (en) | 1996-01-31 |
JPH08208522A (ja) | 1996-08-13 |
NO954485L (no) | 1996-05-10 |
NZ280420A (en) | 1997-03-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI955311A (fi) | Farmaseuttinen koostumuspohja | |
NO20004345L (no) | Farmasøytisk sammensetning | |
FI944832A0 (fi) | Farmaseuttinen koostumus | |
ID18352A (id) | Komposisi-komposisi farmasi | |
ITMI932540A0 (it) | Composizione farmaceutica | |
BR9507768A (pt) | Composição farmacêutica | |
ID29294A (id) | Komposisi farmasi | |
LV11727A (lv) | Farmaceitiska kompozicija | |
FI973229A (fi) | Uusi farmaseuttinen koostumus | |
ITMI941169A0 (it) | Formulazioni farmaceutiche | |
ID18698A (id) | Komposisi farmasi | |
ID25857A (id) | Komposisi farmasi | |
ITMI942166A0 (it) | Composizioni farmaceutiche miorilassanti | |
FI973280A0 (fi) | Farmaseuttinen koostumus | |
LV10579A (lv) | Farmaceitiska kompozicija | |
ITMI962628A0 (it) | Composizione farmaceutica | |
FI962738A0 (fi) | Farmaseuttiset koostumukset | |
BR9605777A (pt) | Composição farmacêutica | |
ID23531A (id) | Komposisi farmasi | |
IT1272935B (it) | Composizione farmaceutica contenente n-acetil-cisteina | |
NO964309D0 (no) | Farmasöytisk sammensetning | |
SE9402924D0 (sv) | Novel pharmaceutical composition | |
KR960016881A (ko) | 제약 조성물 | |
SE9402437D0 (sv) | Pharmaceutical composition | |
ID17133A (id) | Komposisi farmasi |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GB | Transfer or assigment of application |
Owner name: NOVARTIS AG |